↓ Skip to main content

Galantamine for vascular cognitive impairment

Overview of attention for article published in Cochrane database of systematic reviews, January 2006
Altmetric Badge

Mentioned by

twitter
4 X users

Citations

dimensions_citation
91 Dimensions

Readers on

mendeley
237 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Galantamine for vascular cognitive impairment
Published in
Cochrane database of systematic reviews, January 2006
DOI 10.1002/14651858.cd004746.pub2
Pubmed ID
Authors

Jacqueline Birks, David Craig

Abstract

Vascular dementia is the second most common form of dementia. Cholinesterase inhibitors modestly improve a broad range of symptoms in some patients with Alzheimer's disease through enhancement of cholinergic neurotransmission. These drugs may also be beneficial in vascular dementia as reductions in acetylcholine and acetyltransferase activity have been reported.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 237 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Japan 2 <1%
Switzerland 1 <1%
Netherlands 1 <1%
Argentina 1 <1%
Germany 1 <1%
Brazil 1 <1%
Spain 1 <1%
Unknown 227 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 13%
Researcher 29 12%
Student > Ph. D. Student 25 11%
Student > Bachelor 21 9%
Student > Doctoral Student 19 8%
Other 53 22%
Unknown 60 25%
Readers by discipline Count As %
Medicine and Dentistry 74 31%
Psychology 20 8%
Nursing and Health Professions 16 7%
Agricultural and Biological Sciences 11 5%
Neuroscience 11 5%
Other 36 15%
Unknown 69 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2024.
All research outputs
#14,826,439
of 25,432,721 outputs
Outputs from Cochrane database of systematic reviews
#9,897
of 11,493 outputs
Outputs of similar age
#144,889
of 170,986 outputs
Outputs of similar age from Cochrane database of systematic reviews
#44
of 58 outputs
Altmetric has tracked 25,432,721 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,493 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 39.9. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,986 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.